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ABSTRACT 
The aim of this study is to evaluate the effect of lifestyle intervention in J apan巴sepopulation 
with impaired glucose tolerance (IGT). We started the early detection and lifestyle intervention 
of the abnormal glucose tolerance persons in Kofu Town from 2005. W巴setup the standard and 
extracted the abnormal glucose tolerance persons. We performed OGTT in 2005 and 2009 to 
follow up the glucos巴 tolerance.We adopted the lifestyle intervention program in the local public 
clinic. The program was constituted of the diet and exercise therapy. We divided 26 subjects 
into the intervention group (n=13) and the non-intervention group (n=13). The subjects were 
elderly (Age 67.8士9.2years) and not so ov巴rweight(BMI 24.1士3.3kg/m2). In the int巴rvention
group， we observed the improvement in the blood glucose level at 30 min， 60 min after oral 
glucose loading and insulinogenic index value in 2009 compared with those in 2005. (insulinogenic 
index: intervention group; 0.35士0.10μU/ml/mg/dlto 0目70士0.34μU/ml/mg/dl(p=O目006)， 
non-intervention group; 0.57:t 0.12μU/ml/mg/dl to 0.54:t0.09μU/ml/mg/dl (p=0.762)). Our 
results suggest that lifestyle intervention improv巴searly phase insulin secretion in Japanese 
population with IGT. (Accepted on Decemb巴r19， 2012) 




































山町研究7，8， 9， 10) 国外ではDPPstudyll.凶(米国)， 
Da Quing study13 14) (中国)， Malmo studyI5.16) (ス
ウェー デン)， DPS study17凶(フィンランド)が













































経口ブドウ糖負荷前血糖値)， disposition index= 
insulinogenic index X Matsuda index. またイ
ンスリン抵抗性の指標としてMatsudaindex， 




平均インスリン値)凹) HOMA-R (Homeostasis 









Intervention N on-intervention 
Number 13 13 
Male' Female (no.) 4・9 5・8
Age(years) 67.5土8.9 63.8:t 12.0 
Weight(kg) 56.8:t 10.4 59.9:t 12.5 
Body mass index(kg/m') 24.l:t 3.6 24.5:t 3.5 
Fasting plasma glucose (mgl dl) 99.8:t 8.4 94.4:t 7.2 
Fasting serum insulin (μU/ml) 5.0:t 2.5 5.l:t 3.0 
Hemoglobin A1c (%) 5.6 :t0.3 5.7士0.4
Serum total cholesterol (mg/dl) 206.7 :t 31.5 209.l :t 30.l 
Serum triglycerides (mgl dl) 108.5士39.l 144.5:t 96.7 













Intervention group (n= 13) Non-Intervention group (n=13) 
2005 
plasma glucose Omin. in OGTT(mg/dl) 94.4士7.2
plasma glucose 30min. in OGTT(mg/dl) 192.1 :t 20.2 
plasma glucose 60min. in OGTT (mgl dl) 21O.8:t 32.2 
plasma glucose 120min. in OGTT(mg/dl) 167.5:t 21.5 
plasma insulin Omin. in OGTT (μU/ml) 5.0:t 2.5 
plasma insulin 30min. in OGTT (μU/ml) 34.3:t 23.2 
plasma insulin 60min. in OGTT (μU/ml) 57.3士30.0
plasma insulin 12仇m孔 inOGTT(μU/ml) 59.3:t 31.9 
Body weight 56.8:t 10.4 
BMI(kg/m2) 24.1土3.6
HOMA-R 1.2:t 0.6 
Matsuda ind巴瓦 6.1士2.5
Insulinogenic index 0.35土0.10
disposition index 2.0:t 1.6 
Serum triglycerides (mgl dl) 100.6土47.1
Serum LDL-cholesterol(mg/dl) 128.6 :t 34.6 













2009 p value 2005 2ω9 p value 
98.7:t 11.4 N.S 9.8:t 8.4 96.8土1.6 N.S 
160.5土21.4* * く0.001 174.5土23.9 169.2士27.0 N.S 
156.5 :t 42.5'本 く0.001 190.8:t 24.1 187.2:t 36.1 N.S 
148.2:t 37.0 N.S 155.1 :t 27.9 138.2土31.8 N.S 
4.7士2.5 N.S 5.1 :t 3.0 5.7:t 3.8 N.S. 
42.5:t 25.8' 0.01 46.6士26.2 40.9:t 17.6 N.S 
39.0土20.1' 0.024 65.2:t 60.8 6.3土48.7 N.S 
45.6 :t 23.6 * 0.032 84.4:t 71.0 68.0土34.7 N.S 
5.0:t9.8* 0.046 58.2:t 11.4 58.2:t 13.3 N.S 
23.4:t 3.5キ 0.044 24.1 :t 3.1 24.0士3.7 N.S. 
1.2士0.7 N.S. 1.2士0.8 1.4:t 1.1 N.S. 
7.6:t 2.8本 く0.05 6.2士3.0 6.8:t 4.4 N.S 
0.70士0.34* く0∞l 0.57:t 0.12 0.54士0.09 N.S 
5.3:t 5.3' 0.011 2.8士1.2 3.1 :t 1.9 N.S. 
91.7:t 34.3 N.S. 118.4土46.6 95.6土3.4 N.S 
101.9士31.0 N.S. 119.0:t 25.0 105.4士20.9 N.S 
5.3:t 14.9 N.S. 60.7士14.4 5.6:t 16.9 N.S. 
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図1.パスプログラムの流れ
前段階 l回目 2回目 3回目
患者目標 教育導入に同意できる 生活習慣の振り返りが出来る 生活習慣の振り返りが出来る -目標達成度
-目標設定が出来る
検査 . ECG， CVR-R心 目採血(随時血糖， HbAlc) 採血(随時血糖， HbAlc) -採血(随時血糖， HbAlc) 




医師 -頚部血管エコーによるIMT-診察 -診察 -診察
測定" -検査オー ダ -検査オー ダ -検査オー ダ
-家庭血圧測定 -栄養指導の指示簿作成 -糖尿病外来終了後の指示
. 24時間血圧
看護師 -教育パスの説明・同意を得る -計測(体重・体脂肪率) -計測(体重・体脂肪率) -計測(体重・体脂肪率・腹囲)
-問診票の聞き取り -糖尿病手帳の記入 -糖尿病手帳の記入 -糖尿病手帳の記入
-計測(身長1 腹囲) -生活習慣指導 -生活習慣指導 -生活習慣指導(自己目標を
-糖尿病手帳の記入 -歩数計を渡す (2週間) -評価 設定)




栄養士 -目標づくり 食事パフンスに関して 自己評価
-必要な食事単位に関して -目標の見直し -目標の再検討
評価 -カンファレンス実施 カン77レンス実施 カンファレンス実施
a) CVR-R:心拍変動係数 (coefficientof variation R-R interval) 
b) PWV脈波伝播速度 (pulsewave velocity) 
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